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Abstract Elderly population often is encouraged to
practice sports in preventing cardiovascular diseases.
However, evidences exist that intense physical efforts
are related with a higher risk for acute myocardial
infarction and sudden death. Biological markers for
myocardial injury was analyzed in a group of 15
elderly athletes without a history of coronary artery
disease, who participated in the 77th International Sao
Silvestre race (15,000 m) in Sao Paulo City. A
statistical difference was observed between total CPK
activity levels before the run, immediately after the run,
and some time later. Similar results were observed in
the concentration of CK-MB mass. The cardiac tropo-
nin I (TnI-c) levels remained unchanged and within
normal limits during the same time periods. The results
of the present study showed no evidence of myocardial
injury in elderly subjects without a history of coronary
artery disease after participating in long-distance runs,
as confirmed by the analysis of TnI-c levels. The
increase in total CPK activity levels and the concen-
tration of CK-MB mass do not represent myocardial
injury in these subjects.
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Introduction
The benefit resulting from the practice of physical exercises
is not exempt from risks [1, 7, 12, 16] and an increase in the
risk for acute myocardial infarction and sudden death while
exercising or within the subsequent hour.
The detection, by serologic markers, of myocardial
ischemic injuries in patients subjected to intense physical
exertion presents some limitations due to the elevation in
serum levels of creatine phosphokinase MB-isoenzyme
(CK-MB) [15] due to an increase in its level in the skeletal
musculature [2, 17].
The solution to this problem is the analysis of the
serum levels of troponins, regulatory proteins found in
cardiac and skeletal myocytes that modulate the actin–
myosin interaction [6].
We found a few articles in the literature showing
increases in the cardiac troponin levels of young subjects
after highly intensive sports activities such as marathons,
ultra marathons, and Ironman-type triathlons, some of them
performed at high altitudes [3, 5, 9, 11, 13, 14].
In the search to analyze this risk in elderly patients, the only
article investigating the specific behavior of enzymatic changes
was the study by Lucía et al. [10], who found no changes in
cardiac troponin I levels during the Madrid Marathon.
Under these conditions, we proposed to study the enzymatic
profile of normal elderly subjects after long-distance runs such
as the São Silvestre International street race (15,000 m).
Materials and methods
This was a transversal study to evaluate athletes more than
60 years old who participated in the Sao Silvestre
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International street race (15,000 m) held in Sao Paulo city
(Brazil) on December 31, 2001.
Of a group of 114 elderly athletes who had participated
in that marathon run in the previous year and were part of a
cohort of a follow-up health study of elderly athletes in the
Institute of Orthopedics and Traumatology of the Clinics
Hospital of the Faculty of Medicine of the University of
Sao Paulo (IOT-HC-FMUSP), 15 male athletes aged more
than 60 years were invited and accepted participating in this
study.
The inclusion criteria adopted were the following:
1. A regularly active athlete
2. Be part of the cohort of a follow-up health study of
elderly athletes in the IOT-HC-FMUSP.
3. 60 years old or over
4. Male sex
5. Intend to participate in the 77th International Sao
Silvestre Race
6. Have no known history of ischemic coronary disease
7. Willing to sign a free informed consent form
8. Have no clinically uncompensated systemic disease.
Participants were subjected to ergometric and spyromet-
ric tests before participation in the run. All results were
negative for coronary ischemia.
Methods
After reading and signing the informed consent form, the
volunteers started the protocol stages as follows:
Stage 1: Sample collection of whole blood by peripheral
venous puncture of the forearm, 5 days before
the marathon
Stage 2: Collection of a new sample of whole blood by
peripheral venous puncture of the forearm
immediately after the end of the marathon
Stage 3: Sample collection of whole blood by peripheral
venous puncture of the forearm, 2 days after the
marathon run.
Sample collection was performed using the BD
Vacutainer, a vacuum-based sampling system by Becton,
Dickinson and Company consisting of Vacutainer needles
and needle adapters and BD Vacutainer tubes containing
clot-activating gel. After complete retraction of the clots,
the sample was centrifuged for 20 min after which the
serum was separated and frozen at −20°C.
The CPK activity measurement was performed using a
multiparametric automated random-access biochemistry
analyzer, the Cobas Integra 700 integrated analytical unit
made by Roche Diagnostics, and absorption photometry
at 25°C with liquid reagent creatin kinase of Roche
Diagnostics.
The CPK MB-isoenzyme mass was determined using an
automated random-access immunoassay analyzer called
Immulite Turbo made by DPC Diagnostic Product Corpo-
ration, and by chemoluminescence using the Turbo CK-MB
reagent from the same manufacturer.
Cardiac troponin I was determined also using the
automated random-access immunoassay analyzer Immulite
Turbo made by the DPC Diagnostic Product Corporation,
and by chemoluminescence using the Turbo Troponin I
reagent from the same manufacturer.
For the analysis of results, the reference values consid-
ered normal were as follows: CPK, 10–80 IU/l at 25°C;
CK-MB mass up to 4.0 ng/ml; and cardiac troponin I up to
1.0 ng/ml.
One of the study participants did not collect sample 2.
Two participants did not collect sample 3. One sample 1
was lost due to laboratory problems.
All data were statistically analyzed using the statistical
software for Microsoft Excel named Analyse-it, General
and Clinical Laboratory Statistics, version 1.62, from
Analyse-it Software.
The research project officially complied protocol and
was approved by the Ethics Committee for Analysis of
Research Projects of the Clinical Board of the Clinics
Hospital and the Faculty of Medicine of the University of
Sao Paulo under number 215/02.
Results
All athletes were male volunteers in the 60–74 year age
group (mean age: 65.47±4.55 years). The subjects’ average
weight was 67.40±10.51 kg (weight range: 49–88 kg). The
mean height was 1.66±0.06 m, ranging between 1.58 and
1.79 m.
Two participants had systemic artery hypertension
controlled by medication.
Data regarding the values obtained after the analysis of
samples of creatine phosphokinase (CPK), creatine phos-
phokinase isoenzyme MB mass (CK-MB), and cardiac
troponin I (TnI-c) are detailed in Table 1.
The CPK and CK-MB levels obtained immediately after
the run were statistically higher than those obtained before






CPK (IU/l) 93.3±27.2 148.9±37.3 141.8±31.7
CK-MB (ng/ml) 4.993±0.908 6.950±0.823 7.838±1.465
Troponin I (ng/ml) <0.5 <0.5 <0.5
aMean±standard error of the mean
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the run (p<0.001). The troponin I levels were maintained
below 0.5 ng/ml in all samples collected.
Discussion
The world literature reports that among young individuals
subjected to strenuous exertion, sometimes competing at
high altitudes, there may be an increase in the levels of
cardiac troponin I and also of cardiac troponin T [4].
In some cases, physical exertion is accompanied not only
by an increase in troponin but also by cardiac functional
manifestations. Some athletes presented dyspnea, reversible
pulmonary hypertension, and increased levels of cardiac
troponin I associated with right ventricle dysfunction, as
proven by echocardiography [9].
However, some alterations in the cardiovascular system
of elderly individuals can promote higher risk for myocar-
dial injuries. The increase of ventricle wall thickness, the
increase of tension in the ventricle wall, and prolonged
myocardial contraction may result in impaired perfusion of
the endocardial cells [8].
It seems that the coronary flow does not change with
age, but there are no studies to measure it in elderly
individuals without coronary artery disease [4]; this opens
the perspective that, under intense physical exertion, small
changes in this flow may promote injuries in asymptomatic
myocardial cells.
In the single study found in the world literature about
myocardial injury in the elderly after long-distance runs,
Lucía et al. [10], by analyzing the troponin I levels in
elderly people participating in the Madrid Marathon, did
not find any evidence of myocardial injury . It is worth
noting that the number of participants of both sexes in that
single study of an elderly population was ten.
We found significant differences between CPK 1 and
CPK 2 samples, showing that although the initial value was
high, the test contributed to increase that value. However,
when we compared CPK 2 and CPK 3 samples as well as
CPK 1 and CPK 2 samples, no statistical differences were
observed. This phenomenon may be attributed to the
reduced number of subjects participating in the present
study, associated to a few disagreeing CPK values, which
may have contaminated the sample.
The samples collected before the marathon run showed
an increase in the CPK and CK-MB levels. The average of
these values and the fact that almost half the athletes
presented high CPK and CK-MB levels disagree with the
findings published in the literature, where such levels are
normal in most samples collected before the marathon run
[3, 13]. Most probably this is because, as reported by the
athletes themselves, they had been intensely training until
the day before the marathon run. The studies mentioned
above estimate that the athletes had reduced their training
rhythm 1 week before the marathon run and practiced
maintenance exercises only.
We found a pattern of CK-MB increase compared to the
initial sample, although the high values were maintained
after the run. We believe that the high value found in
sample 2 and the maintenance of the result in sample 3 are
due to the release of the marker of the myocardial
musculature injured during the marathon run, proving the
findings shown in the literature.
With such high levels of CPK and CK-MB levels, it is
impossible to detect the presence or absence of concomitant
myocardial injury by just analyzing these substances; thus,
the analysis of cardiac troponin I levels is particularly
important to detect myocardial injury in these athletes.
The cardiac troponin I level of the runners admitted in
this study did not change in any of the samples and was
maintained always below 0.50 ng/ml.
Our findings are close to those reported by Lucía et al. [10].
We observed an expressive increase in the CPK and CK-MB
values in the elderly runners, although they ran a shorter
distance (15 km). The cardiac troponin I value was found to
be within the normal range, showing that up to the distance
they ran the athletes did not present myocardial injury.
Conclusion
Based on the data obtained in this study, we were able to
observe that previously trained elderly people without
previous coronary disease did not present signs of myocar-
dial injury during long-distance runs up to the limit of
15 km.
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